Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 Variants
E. Engelhart, R. Lopez, R. Emerson, C. Lin, C. Shikany, D. Guion, M. Kelley, D. Younger
The paper measures binding affinities of 33 therapeutic antibodies against SARS-CoV-2 variants to identify epitopes and predict future efficacy against RBD mutations.
bioRxiv · Apr 27, 2021Bioengineering